Labcorp to Speak Virtually at the 40th Annual J.P. Morgan Healthcare Conference

West Texas

West Texas
Display for:

No Surprises Act

<span>Labcorp strengthens oncology leadership position with the addition of Personal Genome Diagnostics, a provider of comprehensive liquid biopsy and tissue-based genomic products and services</span>
December 23, 2021

Labcorp strengthens oncology leadership position with the addition of Personal Genome Diagnostics, a provider of comprehensive liquid biopsy and tissue-based genomic products and services

BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 23, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics with a portfolio of comprehensive liquid biopsy and tissue-based products.

Labcorp Strengthens Oncology Leadership Position with the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and Services

December 14, 2021

Army Distaff Foundation honors Ret. Army Col. Deborah Birx, M.D. and Brian Caveney, M.D. with 2021 Dwight D. and Mamie Eisenhower Distinguished Citizen Awards

WASHINGTON, D.C. Dec. 13, 2021 – The Army Distaff Foundation (ADF) is honoring Dr. Deborah Birx and Dr. Brian Caveney for their professional, medical contributions to the U.S. public health and that of Knollwood Military Life Plan Community (Knollwood) during the COVID-19 pandemic. They will receive 2021 Dwight D. & Mamie Eisenhower Distinguished Citizen Awards at the 25th Annual ADF Gala on December 11, 2021. 

Labcorp Announces Initiatives to Enhance Shareholder Value